Evidence map›Paper›PMID 30391228›Full record

ArticleInternational journal for parasitology2019

Analysis of the Babesia microti proteome in infected red blood cells by a combination of nanotechnology and mass spectrometry.

Ruben Magni, Alessandra Luchini, Lance Liotta, Robert E Molestina

Open access · greenAbstract read
In one paragraph

Article in International journal for parasitology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Acquired motility ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. A set of diagnostic tests for detection of active Babesia duncani infection.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  4. Article
  5. Advances inPathogens (Basel, Switzerland) · 2023
    Review
  6. HarnessingVaccines · 2022
    Review
  7. In Silico Survey and Characterization ofPathogens (Basel, Switzerland) · 2021
    Article
  8. Pathogens (Basel, Switzerland) · 2021
    Article
  9. Frontiers in microbiology · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Frontiers in immunology · 2020
    Article
  14. Persistence ofPathogens (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ruben MagniCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Alessandra LuchiniCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Lance LiottaCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Robert E MolestinaProtistology Laboratory, American Type Culture Collection, Manassas, VA 20110, USA. Electronic address: rmolestina@atcc.org.
George Mason University · USAmerican Type Culture Collection · US

Funding

Early Detection of Congenital Chagas DiseaseR01AI087776 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2010 to 2014
$2.9M
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammationR01AR068436 · NIAMS · GEORGE MASON UNIVERSITY · PI LIOTTA, LANCE ALLEN · 2015 to 2017
$1.7M
Protein painting identifies therapeutic targets at protein-protein interfacesR33CA206937 · NCI · GEORGE MASON UNIVERSITY · PI LIOTTA, LANCE ALLEN · 2016 to 2018
$1.2M
High sensitivity multiplex detection of tick borne infection peptidesR21AI138135 · NIAID · GEORGE MASON UNIVERSITY · PI LUCHINI, ALESSANDRA · 2019 to 2020
$503k
Bridging adult to pediatric markers of tuberculosis disease severityR21HD097472 · NICHD · GEORGE MASON UNIVERSITY · PI LIOTTA, LANCE ALLEN · 2019 to 2020
$426k
NCI NIH HHS R33 CA206937NIAID NIH HHS R01 AI087776NIAID NIH HHS R21 AI138135NIAMS NIH HHS R01 AR068436NICHD NIH HHS R21 HD097472
6 · The paper itself

Abstract

Proteomics of Babesia microti has lagged behind other apicomplexans despite recent genome and transcriptome studies. Here, we used a combination of nanotechnology and mass spectrometry to provide a proteomic profile of B. microti acute infection. We identified ∼500 parasite proteins in blood with functions such as transport, carbohydrate and energy metabolism, proteolysis, DNA and RNA metabolism, signaling, translation, lipid biosynthesis, and motility and invasion. We also identified surface antigens with roles in the immune response to the parasite. This first evaluation of the B. microti proteome in erythrocytes provides information for the study of intracellular survival and development of diagnostic tools using mass spectrometry.

Indexed as

AnimalsBabesia microtiCricetinaeErythrocytesMass SpectrometryNanotechnologyProteomeProteomicsProtozoan ProteinsProteomeProtozoan ProteinsBabesiaBabesiosisDiagnosisNanotechnologyProteomeTick

Identifiers

PMID30391228
PMCPMC10548858
OpenAlexW2899481777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.